Navigation Links
Johnson & Johnson Symposium Honors 2011 Recipient of The Dr. Paul Janssen Award for Biomedical Research
Date:9/14/2011

NEW YORK, Sept. 14, 2011 /PRNewswire/ -- Napoleone Ferrara, M.D., will receive the Johnson & Johnson Dr. Paul Janssen Award for Biomedical Research, including a $100,000 prize, this week during a series of events that celebrate his central role in the discovery of vascular endothelial growth factor (VEGF), the core signaling molecule of angiogenesis. His research has opened the door to the development of a new class of therapeutics to combat a serious eye disorder and contributed to the development of new oncology therapeutics. The Award aims to extend the legacy of Dr. Paul Janssen, an exceptionally gifted and passionate scientist who revolutionized modern medicine and inspired a new generation of researchers, by honoring the work of an active scientist in academia, industry or a scientific institute who has made a significant contribution to advancing human health.

(Photo:  http://photos.prnewswire.com/prnh/20110914/NY68250)

"Dr. Ferrara's groundbreaking research has made a direct impact on the quality of life of many thousands of people," said Paul Stoffels, M.D., Worldwide Chairman, Pharmaceuticals, Johnson & Johnson. "We are pleased to recognize Dr. Ferrara's important achievements in advancing human well-being and his ongoing commitment to scientific innovation that embody the spirit of Dr. Paul Janssen."

Dr. Ferrara received recognition for this achievement at a reception last night and is also being honored during a scientific symposium today at the New York Academy of Sciences in New York. A formal award ceremony to honor Dr. Ferrara will also take place at the Dr. Paul Janssen Research Center in Beerse, Belgium tomorrow.

The symposium will feature presentations by Dr. Ferrara and other internationally renowned experts who have a seminal role in advancing anti-angiogenic therapies for ocular di
'/>"/>

SOURCE Johnson & Johnson
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2 3 4 5

Related biology technology :

1. Dr. Eric Johnson Joins Transgenomic as Medical Director for Laboratory Services
2. Johnson & Johnson and Crucell Reach Agreement on Intended Public Offer of Euro 24.75 per Ordinary Share of Crucell
3. aTyr Pharma Appoints Catharine E. Johnson As Senior Vice President of Business Development
4. Johnson & Johnson Consumer Companies, Inc., Unveils CYTOMIMIC(TM) Technology at 68th Annual Meeting of the American Academy of Dermatology
5. Johnson & Johnson Honors 2009 Recipient of The Dr. Paul Janssen Award for Biomedical Research
6. Cempra Pharmaceuticals Announces Appointment of John H. Johnson to Board of Directors
7. Johnson & Johnson Completes Acquisition of Cougar Biotechnology
8. Johnson & Johnson Completes Initial Tender Offer for Cougar Biotechnology
9. Johnson & Johnson Announces Regulatory Clearance for Its Planned Acquisition of Cougar Biotechnology
10. Johnson & Johnson Begins Tender Offer to Acquire Cougar Biotechnology
11. Johnson & Johnson Announces Definitive Agreement to Acquire Cougar Biotechnology, Inc.
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:4/21/2015)... YourEncore, an Indianapolis, Indiana-based company that ... and food sciences industries solve complex development, regulatory ... Research Excellence and Safety (ACRES), a Massachusetts-based non-profit ... have partnered to speed innovation in the medical ... to ACRES experts with proven experience, tools, and ...
(Date:4/20/2015)... , April 20, 2015  Ardelyx, Inc. ... focused on cardio-renal, gastrointestinal and metabolic diseases, today ... has joined the Company,s Board of Directors. Dr. ... board level experience, having built and led teams ... regulatory approval and into healthcare systems globally. ...
(Date:4/20/2015)... , April 20, 2015 /CNW/ - Portage Biotech ... Securities Exchange: PBT.U), is pleased to announce that its ... a collaborative research study that showed one of its ... inflammation in brain tissue through inhibition of NFkB signalling ... The permeability of the blood brain barrier ...
(Date:4/18/2015)... Aurigene and its partner ... presenting data at the poster sessions from two ... Annual Meeting (April 18-22 in Philadelphia, ... http://photos.prnewswire.com/prnh/20130418/608115 ) , Aurigene will present ... molecule inhibitors program, which is currently in preclinical ...
Breaking Biology Technology:YourEncore and ACRES Partner to Drive Innovation in Clinical Research 2YourEncore and ACRES Partner to Drive Innovation in Clinical Research 3Ardelyx Appoints Dr. Annalisa Jenkins to Its Board of Directors 2Ardelyx Appoints Dr. Annalisa Jenkins to Its Board of Directors 3Ardelyx Appoints Dr. Annalisa Jenkins to Its Board of Directors 4Portage's CPP Platform Delivers a Peptide Cargo Across Blood Brain Barrier 2Portage's CPP Platform Delivers a Peptide Cargo Across Blood Brain Barrier 3Aurigene to Present its NAMPT and IRAK-4 Inhibitors Programs at AACR 2015 2
... REDWOOD CITY, Calif., Feb. 17, 2011 Codexis, Inc. (Nasdaq: ... U.S. Senator from North Dakota, has been elected to the ... in January 2011 after a 30-year career in the U.S. ... "We are very pleased to welcome Byron Dorgan to our ...
... Healthcare has announced the formation of a Medical Advisory ... Director is Dr. Armand B. Cognetta, distinguished Dermatologist and ... is recognized as a leader and innovator in his ... advocacy in the ongoing development of the Company,s leading ...
... LA JOLLA, Calif., Feb. 17, 2011 CalciMedica, ... inflammatory and autoimmune diseases, today announced that it ... 1 clinical trial of CM2489. CM2489 is a ... studied as a once-daily oral therapeutic for patients ...
Cached Biology Technology:Former Senator Byron Dorgan Elected to Codexis Board 2Sensus Healthcare Announces the Formation of a Medical Advisory Board 2CalciMedica Initiates Phase I Clinical Trial of First CRAC Channel Inhibitor (CCI) for Psoriasis 2
(Date:4/8/2015)... , April 8, 2015  Infinisource, a leading ... services, and Morpho, a leading supplier of biometric ... produce the market,s most advanced biometrically-enabled time clock, ... NXG time clock is setting a bold, new ... data for the small and mid-size employer. When ...
(Date:4/2/2015)... Sweden , April 2, 2015 ... for Q1 2015 attributed to somewhat higher than 125 ... in the year-end report 2014 that revenues for Q1 ... that the company reported for Q4 2014. The operating ... to be negative. The complete interim report will as ...
(Date:3/31/2015)... 31, 2015  Elephant Talk Communications Corp. (NYSE MKT: ... of Software Defined Network Architecture (ET Software DNA® 2.0) ... of approximately $20.4 million for the year ended December ... for the year ended December 31, 2013. ... had completed its multi-year transition away from its legacy ...
Breaking Biology News(10 mins):iSolved Time Clock Offers Unmatched Accuracy due to Morpho Biometrics 2iSolved Time Clock Offers Unmatched Accuracy due to Morpho Biometrics 3Fingerprint Cards Revises Revenues for Q1 2015 2Elephant Talk Reports 2014 Fourth Quarter and Year End Financial Results 2Elephant Talk Reports 2014 Fourth Quarter and Year End Financial Results 3Elephant Talk Reports 2014 Fourth Quarter and Year End Financial Results 4Elephant Talk Reports 2014 Fourth Quarter and Year End Financial Results 5Elephant Talk Reports 2014 Fourth Quarter and Year End Financial Results 6
... is always a delicate affair. Few researchers, however, ... whose working laboratory aboard the International Space Station ... Earth, traveling at some 17,000 miles per hour. ... University,s Biodesign Institute, is using the ISS platform ...
... PA. -- While most farmers consider viruses and fungi ... wild plants adapt to extreme conditions, according to a ... the hardiness of plants is a key to sustainable ... addition to avoiding possible conflicts over scare resources, said ...
... not translated into proteinare key to physically manipulating DNA in ... Institute. These non-coding RNA-activators (ncRNA-a) have a crucial role in ... say, and have also been connected with diseases, including some ... article of the journal Nature , a team of ...
Cached Biology News:International space station plays host to innovative infectious disease research 2International space station plays host to innovative infectious disease research 3International space station plays host to innovative infectious disease research 4International space station plays host to innovative infectious disease research 5International space station plays host to innovative infectious disease research 6Microbes team up to boost plants' stress tolerance 2'Activating' RNA takes DNA on a loop through time and space 2'Activating' RNA takes DNA on a loop through time and space 3
... This CE-based system provides clear advantages ... (viral load, gene expression), mutation analysis, ... easy-to-use system with microplate connectivity is ... and quality control. The P/ACE ...
The imaging screen-K (Kodak), tritium, is a 20 x 25 cm storage phosphor screen that is used for the quantitation and imaging of 32P, 33P, 35S, 14C, and 3H....
The optional fixed lens, 105 mm, is for use with the VersaDoc imaging systems for imaging small samples at high resolution....
The filter 640DF35 for the Molecular Imager FX is a band pass filter for Texas Red dye....
Biology Products: